What is Emmessar Biotech & Nutrition share price return in the past 10 years?

Emmessar Biotech & Nutrition Ltd share price has appreciated 17.9% annually (CAGR) over the past ten years.

What is the P/E ratio of Emmessar Biotech & Nutrition?

The latest standalone P/E ratio of Emmessar Biotech & Nutrition as of 20-Dec-2024 is 25.96.

What is the P/B ratio of Emmessar Biotech & Nutrition?

The latest standalone P/B ratio of Emmessar Biotech & Nutrition as of 20-Dec-2024 is 2.89.

Emmessar Biotech & Nutrition Ltd - Stock Valuation and Financial Performance

Name: Emmessar Biotech & Nutrition
Brand: Emmessar Biotech & Nutrition

BSE: 524768 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Emmessar Biotech&Nut Share Price

₹44.99 0.99 2.25%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Emmessar Biotech&Nut

Based on:

Data

M-Cap below 100cr DeciZen not available

Emmessar Biotech & Nutrition stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

25.96

Market Cap:

22.5 Cr.

52-wk low:

23.7

52-wk high:

Is Emmessar Biotech & Nutrition Ltd an attractive stock to invest in?

1. Is Emmessar Biotech & Nutrition Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Emmessar Biotech & Nutrition Ltd is a good quality company.

2. Is Emmessar Biotech & Nutrition Ltd undervalued or overvalued?

The key valuation ratios of Emmessar Biotech & Nutrition Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Emmessar Biotech & Nutrition Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Emmessar Biotech & Nutrition Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Emmessar Biotech&Nut:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	-10.5%	-59.4%	79.5%	31.5%	9%	18.9%	45.3%	15.7%	15%	11.4%	-
Value Creation Index ⓘ	-1.8	-5.2	4.7	1.3	-0.4	0.4	2.2	0.1	0.1	-0.2	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	2.2	2	2.6	1.3	0.6	3.4	7	0.4	1	0.6	1
Sales YoY Gr.	-	-10.1%	33.5%	-52.5%	-49.6%	439.7%	105.6%	-94.9%	183.3%	-45.1%	-
Adj EPS ⓘ	-0.2	0.4	2.4	1.8	1.5	1.9	2.9	0.6	1	1.5	1.7
YoY Gr.	-	NA	555.6%	-22.5%	-19.7%	27.9%	54.3%	-79.7%	69.5%	50%	-
BVPS (₹) ⓘ	2.8	1.8	4.2	6	7	8.5	11.4	12.4	13.3	14.8	15.6
Adj Net Profit ⓘ	-0.1	0.2	1.2	0.9	0.7	0.9	1.5	0.3	0.5	0.8	1
Cash Flow from Ops. ⓘ	0	0.4	0.8	0.7	0.4	1	0.5	2.3	0.4	0.6	-
Debt/CF from Ops. ⓘ	0	0	0	0	0.2	0	0	0	0.2	0.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-14.1%	-2.3%	-56.9%	-45.1%
Adj EPS ⓘ	NA	0.4%	-19.7%	50%
BVPSⓘ	20.6%	16.1%	9.1%	11.1%
Share Price	17.9%	33%	17.2%	72.4%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	-8.1	15.6	78.6	36	22.6	24.1	29.1	5	7.8	10.7	11.4
Op. Profit Mgn % ⓘ	-6.5	0.6	8.6	-33.3	-101.6	-11.9	12.1	-242.5	-67.1	-194.3	-118.5
Net Profit Mgn % ⓘ	-5.5	9	44.8	72.9	116.5	27.6	20.7	80.9	49.2	135.3	105.5
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	0
Working Cap Days ⓘ	126	175	152	333	905	193	124	2,044	326	512	2,540
Cash Conv. Cycle ⓘ	63	64	40	39	187	47	57	1,347	38	84	2,355

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 11.40%

Sales growth is good in last 4 quarters at 60.26%

Sales growth has been subdued in last 3 years -56.89%

Net Profit has been subdued in last 3 years -19.73%

Latest Financials - Emmessar Biotech & Nutrition Ltd.

	Standalone	Consolidated
TTM EPS (₹)	1.7	-
TTM Sales (₹ Cr.)	0.8	-
BVPS (₹.) ⓘ	15.6	-
Reserves (₹ Cr.) ⓘ	3	-
P/BV ⓘ	2.89	-
PE ⓘ	25.96	-

From the Market
52 Week Low / High (₹)	23.69 / 64.00
All Time Low / High (₹)	1.00 / 64.00
Market Cap (₹ Cr.)	22.5
Equity (₹ Cr.)	5
Face Value (₹)	10
Industry PE ⓘ	44.3

Management X-Ray of Emmessar Biotech&Nut:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Emmessar Biotech&Nut

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Emmessar Biotech&Nut

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	2.19	1.97	2.63	1.25	0.63	3.40	6.99	0.36	1.02	0.56
Operating Expenses ⓘ	2.33	1.96	2.41	1.67	1.27	3.80	6.14	1.26	1.71	1.64
Manufacturing Costs	0.93	0.41	0.73	0.39	0.25	1.37	1.63	0.04	0.05	0.05
Material Costs	0.80	1	0.98	0.63	0.12	1.54	3.53	0.13	0.40	0.20
Employee Cost	0.28	0.31	0.39	0.41	0.58	0.58	0.64	0.77	0.84	0.96
Other Costs ⓘ	0.32	0.24	0.31	0.24	0.32	0.31	0.34	0.32	0.42	0.43
Operating Profit ⓘ	-0.14	0.01	0.23	-0.42	-0.64	-0.40	0.85	-0.89	-0.69	-1.08
Operating Profit Margin (%)	-6.6%	0.6%	8.6%	-33.3%	-101.0%	-11.9%	12.1%	-245.0%	-67.6%	-194.0%
Other Income ⓘ	0.06	0.26	0.98	1.27	1.30	1.47	1.47	1.92	1.75	1.99
Interest ⓘ	0	0	0.01	0	0	0	0	0	0	0
Depreciation ⓘ	0.07	0.03	0.01	0.05	0.08	0.06	0.06	0.09	0.09	0.10
Exceptional Items ⓘ	0	-0.92	0	0	-0.29	-0.26	0	0	0	0
Profit Before Tax ⓘ	-0.16	-0.68	1.18	0.80	0.29	0.74	2.25	0.93	0.97	0.81
Tax ⓘ	-0.04	-0.21	0	-0.12	-0.24	-0.02	0.80	0.46	0.46	0.06
Profit After Tax	-0.12	-0.47	1.18	0.91	0.53	0.75	1.45	0.48	0.50	0.75
PAT Margin (%)	-5.4%	-23.6%	44.8%	72.9%	84.7%	22.2%	20.7%	130.3%	49.4%	135.0%
Adjusted EPS (₹)	-0.2	-0.9	2.4	1.8	1.1	1.5	2.9	1.0	1.0	1.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	1.37	0.91	2.09	2.98	3.51	4.26	5.70	6.17	6.66	7.40
Share Capital ⓘ	5	5	5	5	5	5	5	5	5	5
Reserves ⓘ	-3.62	-4.09	-2.91	-2.01	-1.49	-0.73	0.70	1.17	1.67	2.41
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0	0	0	0	0.07	0	0	0	0.08	0.11
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0.07	0	0	0	0.08	0.11
Trade Payables	0.31	0.20	0.20	0.01	0.58	0.80	0.50	0.02	0	0.01
Others Liabilities ⓘ	0.74	1.05	0.81	0.69	0.53	0.35	1.29	1.41	1.35	1.25
Total Liabilities ⓘ	2.42	2.16	3.11	3.68	4.68	5.41	7.49	7.60	8.09	8.77
Fixed Assets
Gross Block	3.11	1.31	1.30	2.88	2.63	2.60	2.60	2.02	2.04	2.04
Accumulated Depreciation	1.68	0.58	0.58	0.63	0.64	0.68	0.74	0.56	0.65	0.74
Net Fixed Assetsⓘ	1.42	0.73	0.72	2.25	1.99	1.91	1.86	1.46	1.40	1.31
CWIP ⓘ	0	0	0.80	0	0	0	0	0	0	0
Investmentsⓘ	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Inventories	0.69	0.36	0.32	0.09	0.73	1.15	0.07	0.07	0.14	0.09
Trade Receivables	0.04	0.36	0.04	0.03	0.04	0.03	2.71	0.01	0.01	0.02
Cash Equivalents ⓘ	0.02	0.43	0.32	0.27	0.71	1.88	2.47	4.58	5.19	6.18
Others Assetsⓘ	0.24	0.27	0.89	1.03	1.21	0.44	0.38	1.47	1.35	1.16
Total Assets ⓘ	2.42	2.16	3.11	3.68	4.68	5.41	7.49	7.60	8.09	8.77

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	-0.01	0.44	0.75	0.74	0.39	1.03	0.47	2.27	0.38	0.64
PBT ⓘ	-0.16	-0.68	1.18	0.80	0.58	1	2.25	0.93	0.97	0.81
Adjustment ⓘ	0.07	0.73	0.06	0.01	-0.07	-0.31	-0.07	-0.13	-0.15	-0.42
Changes in Working Capital ⓘ	0.08	0.39	-0.45	-0.02	-0.12	0.34	-1.61	1.76	-0.5	0.24
Tax Paid ⓘ	0	0	-0.04	-0.05	0	0	-0.10	-0.29	0.06	0.02
Cash Flow From Investing Activity ⓘ	0	-0.46	-0.74	-0.69	-0.37	-1.06	0.01	-2.61	-0.55	-0.64
Capex	0	-0.02	-0.01	-0.78	0	0	0	-0.31	-0.03	0
Net Investments	0	0	0	0.08	-0.41	-1.19	-0.11	-2.45	-0.78	-0.99
Others ⓘ	0	-0.44	-0.74	0.01	0.04	0.14	0.12	0.14	0.26	0.35
Cash Flow From Financing Activityⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Net Cash Flow ⓘ	-0.01	-0.02	0.01	0.05	0.01	-0.03	0.48	-0.34	-0.17	0

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	-7.98	-40.75	78.73	36	16.42	19.4	29.1	8.01	7.85	10.66
ROCE (%)	-10.49	-59.37	79.46	31.46	9	18.87	45.29	15.71	14.99	11.42
Asset Turnover Ratio	0.98	0.89	1.03	0.39	0.15	0.67	1.08	0.05	0.13	0.07
PAT to CFO Conversion(x)	N/A	N/A	0.64	0.81	0.74	1.37	0.32	4.73	0.76	0.85
Working Capital Days
Receivable Days	17	36	27	10	21	3	71	1,362	4	11
Inventory Days	82	93	46	56	236	101	32	68	37	74
Payable Days	105	93	76	61	857	163	67	753	0	17

Emmessar Biotech & Nutrition Ltd Stock News

Emmessar Biotech & Nutrition Ltd FAQs

What is the share price of Emmessar Biotech&Nut?

Company share prices are keep on changing according to the market conditions. The closing price of Emmessar Biotech&Nut on 20-Dec-2024 16:59 is ₹44.99.

What is the market cap of Emmessar Biotech&Nut?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Emmessar Biotech&Nut stood at ₹22.48.

What is the P/E ratio of Emmessar Biotech&Nut?

The latest P/E ratio of Emmessar Biotech&Nut as of 20-Dec-2024 16:59 is 25.96.

What is the P/B ratio of Emmessar Biotech&Nut?

The latest P/B ratio of Emmessar Biotech&Nut as of 20-Dec-2024 16:59 is 2.89.

What is the 52-week high and low of Emmessar Biotech&Nut?

The 52-week high of Emmessar Biotech&Nut is ₹64.00 and the 52-week low is ₹23.69.

What is the TTM revenue of Emmessar Biotech&Nut?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Emmessar Biotech&Nut is ₹0.82 ( Cr.) .

About Emmessar Biotech & Nutrition Ltd

Emmessar Biotech & Nutrition Ltd., was originally started as Emmessar Chemical Industries Ltd on March 17,1992, for manufacturing Super Speciality Fine Chemicals. The Company succeeded in developing many Speciality Fine Chemicals in its own In-house R&D, which was recognised on January 15, 1996 by DSIR, Ministry of Science & Technology, Government of India, New Delhi .

When there was a realisation that some of the Speciality Chemicals developed in our R&D and exported to USA & Europe were being used in Healthcare formulations, the Company decided to re-orient itself and enter the Healthcare business, which is poised for phenomenal growth in the coming decades.

Concurrently the company also realised that some of the Speciality Chemicals are actually Vital Micro Nutrients, which are being used in the research worldwide as tools of Biotechnology, the Company took a conscious decision to enter the field of Biotechnology & Healthcare.

To ensure that the name is representative of its activity, the company's name was changed from Emmessar Chemical Industries Ltd., to Emmessar Biotech & Nutrition Ltd., on 7th April 2000.

In the process of pursuing its own R&D and exploring commercial market potentials for their products in the field of Healthcare, the company came across another reputed company in USA Vibrant Life in California.

Intense exchange of ideas & technical information between Emmessar Biotech & Nutrition Ltd., & Vibrant Life, resulted in development of several new concepts and new technologies - combining different schools of thought such as Nutraceuticals, Cosmeceuticals, Ayurveda & Biotechnology.

The company has developed many products covering different areas of healthcare that include obstinate Skin problems & debilitating chronic physical ailments.

Emmessar Biotech & Nutrition Ltd., is a Public Limited Company, with the Paid-up Share Capital of about Rs. 50.00 million (over $ 1.00 million). The Stocks of Emmessar Biotech & Nutrition Ltd., are traded in The Bombay Stock Exchange Ltd.

Product range of the company includes:

Present products